HHMI News
  Top Stories  
dashed line
  Research News  
dashed line
  Science Education News  
dashed line
Institute News
dashed line

Erin O’Shea Named Chief Scientific Officer at HHMIsmall arrow

dashed line

HHMI Launches Tangled Bank Studios small arrow

dashed line

Eric Betzig to Deliver Public Talk at Janelia Farmsmall arrow

dashed line

Moresmall arrow

dashed line
  NewsSrch  
dashed line
  Noticias  

FOR FURTHER
INFORMATION:


Cindy Fox Aisen
(317)843-2276
aisenc@hhmi.org
dashed line Howard Hughes
Medical Institute

(301) 215-8500


News Alert
Sign Up
Institute News

July 07, 2005
42 Biomedical Scientists Worldwide Named HHMI International Research Scholars

Tuberculosis, malaria, hemorrhagic fevers, and anthrax all are infectious and parasitic diseases posing a global problem that calls for a global solution. So the Howard Hughes Medical Institute (HHMI) is awarding $17.5 million to 42 outstanding scientists in 20 countries to tackle the mysteries of the molecular and genetic mechanisms underlying infectious and parasitic disease. What they learn could help identify potential new drug targets and develop vaccines.

Nearly 500 scientists from 62 countries applied for the five-year awards. HHMI selected researchers from Argentina, Australia, Brazil, Canada, China, Denmark, France, Germany, Hungary, India, Israel, Mali, Mexico, Portugal, Russia, South Africa, Spain, Switzerland, Thailand, and Uruguay. Each will receive $350,000 to $500,000 U.S. dollars over five years.


“HHMI is supporting scientists of the highest quality in their home countries.”
Thomas R. Cech

“Through its international program, HHMI is supporting scientists of the highest quality in their home countries,” said Institute President Thomas R. Cech, a Nobel prize-winning chemist. “We also bring these international scholars together with each other and with other scientists in the HHMI community to create an international network of scientific excellence.”

Since HHMI awarded its first infectious diseases and parasitology grants in 2000, more than 50 transnational collaborations have sprung from annual science meetings where the international research scholars gather to present their research and learn what their colleagues from around the world are doing.

“HHMI's international program underscores a growing recognition of the international scope of science and of the way international cooperation invigorates research,” said Peter J. Bruns, HHMI vice president for grants and special programs. “HHMI's support of these scientific leaders in their home countries encourages the most creative researchers, strengthens their research environments, and provides vital educational opportunities for upcoming scientists. Networking these scientists with each other and with our domestic investigators yields further unique opportunities for innovation.”

For example:

  • Rajesh Gokhale is a talented young scientist who, despite attractive job offers in the United States, chose to return to his native India to study the unique mechanisms used by Mycobacterium tuberculosis , which causes TB, to modulate the proteins and lipids of its cell walls in response to changes in its environment. Understanding this “enzymatic crosstalk” in M. tuberculosis could help explain the subtle ways that the pathogen generates different reactions under varying circumstances.

  • Valerie Mizrahi of the University of the Witwatersrand in Johannesburg, South Africa, a recognized leader in tuberculosis research, recently was named co-director of the only medical Centre of Excellence established by the South African Department of Science and Technology. Mizrahi studies the mechanisms underlying TB's remarkable ability to adapt to adverse conditions and persist in a dormant state from which it can reactivate to cause disease. She also devotes considerable effort to mentoring young South African scientists. This is her second HHMI infectious diseases and parasitology research award.

  • Sumalee Kamchonwongpaisan from Bangkok, Thailand, will investigate how artemisinin, an effective antimalarial drug, clears parasites from infected red blood cells. Understanding the precise mechanisms of artemisinin action could lead to new targets for better drugs for treating malaria. Kamchonwongpaisan already is collaborating with two other HHMI international research scholars, Alan Cowman and Brendan Crabb, who do malaria research at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia.

Half of the new awardees are first-time HHMI grant recipients. The other 21 are current HHMI international research scholars.

The Institute also supports the work of outstanding scientists in the Baltics, Central and Eastern Europe, Russia and Ukraine and of another group from Latin America and Canada. Competitions are currently under way for grants in both programs.

   

MORE HEADLINES

bullet icon

RESEARCH NEWS

12.21.12 | 

Search for Epigenetic Decoder Leads Scientists to Rett Syndrome

12.20.12 | 

Scientists Find Mechanism that Triggers Immune Responses to DNA

12.02.12 | 

New Software Speeds Analysis of Animal Behavior
Noticias del HHMI Search News Archive

Download Story PDF

Requires Adobe Reader
Versión en españolsmall arrow

Related Links

AT HHMI

bullet icon

2005 HHMI International Research Scholars in Infectious Diseases and Parasitology

bullet icon

Frequently Asked Questions - HHMI International Program

bullet icon

International Program

dashed line
 Back to Topto the top
© 2012 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | email: webmaster@hhmi.org